0G85 Stock Chart & Stats
kr1.82
kr0.00(0.00%)
At close: 4:00 PM EDT
kr1.82
kr0.00(0.00%)
Day’s Range― - ―
52-Week Rangekr1.82 - kr1.82
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
kr420.15M
Enterprise Valuekr268.87
Total Cash (Recent Filing)kr43.09M
Total Debt (Recent Filing)kr0.00
Price to Earnings (P/E)―
Beta0.00
Next Earnings
Nov 11, 2026Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.12
Shares Outstanding394,878,140
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio0.34
Price to Book (P/B)0.85
Price to Sales (P/S)4.14
P/FCF Ratio-2.66
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-0.08
Revenue Forecast (FY)kr41.00M
Bulls Say, Bears Say
Bulls Say
Improving Revenue GrowthImproving TTM revenue indicates that BrainCool is gaining commercial traction in temperature-management therapies. If this trend persists, expanding hospital adoption can support greater device utilization, increase consumables demand, and provide a foundation for future operating leverage.
Debt-Free Balance SheetA debt-free, conservatively financed balance sheet reduces leverage and refinancing risk while preserving flexibility to fund product development and commercialization. The sizable equity cushion provides greater resilience as BrainCool works to improve profitability and scale its operations.
Recurring Consumables Revenue ModelThe installed-base model can create recurring revenue beyond the initial equipment sale because each treatment may require single-use consumables. As adoption expands across hospitals, this structure can deepen customer relationships, improve revenue visibility, and support longer-term commercial scalability.
Bears Say
Persistent UnprofitabilityPersistent negative gross profit and operating losses show that BrainCool has not yet established a stable, scalable profit model. Continued unprofitability may restrict internal funding capacity and makes future earnings improvement dependent on stronger economics from sales growth and cost control.
Significant Cash BurnSubstantial negative operating and free cash flow means reported losses are translating into real cash outflows, increasing the resources required to sustain operations. If cash generation does not improve, BrainCool may need to reduce investment or seek additional funding to continue its growth plans.
Equity Erosion RiskNegative returns on the equity base indicate that shareholder capital is not currently generating positive economic returns. If losses continue, the equity cushion can erode over time and the company may face greater pressure to preserve liquidity, improve margins, or raise capital.
BrainCool AB News
0G85 FAQ
What was BrainCool AB’s price range in the past 12 months?
BrainCool AB lowest share price was kr1.82 and its highest was kr1.82 in the past 12 months.
What is BrainCool AB’s market cap?
BrainCool AB’s market cap is kr420.15M.
When is BrainCool AB’s upcoming earnings report date?
BrainCool AB’s upcoming earnings report date is Nov 11, 2026 which is in 49 days.
How were BrainCool AB’s earnings last quarter?
BrainCool AB released its earnings results on Aug 12, 2026. The company reported kr0 earnings per share for the quarter.
Is BrainCool AB overvalued?
According to Wall Street analysts BrainCool AB’s price is currently Overvalued.
Does BrainCool AB pay dividends?
BrainCool AB does not currently pay dividends.
What is BrainCool AB’s EPS estimate?
BrainCool AB’s EPS estimate is 0.
How many shares outstanding does BrainCool AB have?
BrainCool AB has 394,878,140 shares outstanding.
What happened to BrainCool AB’s price movement after its last earnings report?
BrainCool AB reported an EPS of kr0 in its last earnings report. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of BrainCool AB?
Currently, no hedge funds are holding shares in GB:0G85
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
BrainCool AB
BrainCool AB (publ), a medical technology company founded in 2010 and headquartered in Lund, Sweden, focuses on the development, commercialization, and distribution of advanced medical cooling systems. Operating with its subsidiaries, the company caters to the healthcare sector, primarily serving the Swedish market, by providing innovative solutions for various conditions including stroke, sudden cardiac arrest, oral mucositis, and migraine. Their product line features the BrainCool and RhinoChill systems, specifically engineered to deliver swift therapeutic cooling in emergency situations, thereby ensuring uninterrupted patient care. To mitigate the risk of oral mucositis, BrainCool offers the Cooral system, renowned for its user-friendly design for medical professionals. Furthermore, the IQool system boasts an intuitive interface complemented by informative graphics and an automatic feedback loop, empowering clinicians to dedicate their attention to patient management rather than device operation.